USP17L15

Q-omics provides the consensus-scored USP17L15 profile across patient tissues and cancer cell-line models. USP17L15 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in BRCA. Additionally, USP17L15 RNA expression shows 127 significant mutation-linked associations, with the highest sampling consensus in BRCA. Together, these results highlight BRCA as cancer lineages where USP17L15 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes USP17L15 survival associations across molecular data types. USP17L15 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

USP17L15 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	BRCA (105)	view →

This table ranks reproducible USP17L15 RNA expression–survival associations across cancer types. High USP17L15 expression shows unfavorable associations in BRCA. The BRCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BRCA as the clearest survival context for USP17L15 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.573	0.924	<.001	105	view →

Pink = unfavorable, green = favorable. all 1 lineages →

USP17L15-BRCA (OS)

Explore this curve interactively →